The trademark application TANGLEVID was filed by Avid Radiopharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 1, 2020, and it was registered by office on January 8, 2021 without any oppositions.
The application was filed in English (Italian was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on November 23, 2020.
Goods And Services
The mark was filed in class 5 with following description of goods:
Diagnostic agents, preparations and substances for medical purposes
Diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use
Radiopharmaceutical diagnostic preparations for medical use
Radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases.